Kuvura Kanseri Yumwijima Ubushinwa 2026: Ubuvuzi bugezweho & Igiciro - Ibitaro Byegereye 

Kuvura kanseri y'umwijima mu Bushinwa 2026 byahindutse mu gihe cyagenwe neza, byibanda ku kugabanya ibyabaye nyuma yo kubagwa binyuze mu byiciro ndetse no kuvura hamwe. Kanseri y'umwijima, cyane cyane kanseri ya hepatocellular (HCC), ubu iracungwa hakoreshejwe uburyo bwo gukingira indwara, imiti igamije, hamwe n’ibikorwa byaho bigamije ingaruka ziterwa n’umuntu ku giti cye. Impuguke z’impuguke ziheruka 2026 zishimangira kumenya abarwayi bafite ibyago byinshi hakiri kare no gukoresha imiti itunganijwe nka PD-1 inhibitor ihujwe n’imiti igabanya ubukana kugira ngo imibereho irusheho kuba myiza.

Sobanukirwa n'iterambere rya Kanseri y'umwijima mu Bushinwa 2026

Imiterere ya kanseri y'umwijima Ubuyobozi mu Bushinwa bwahindutse ku buryo bugaragara mu 2026. Bitewe n’ubushakashatsi bwimbitse bw’ubuvuzi no gushyira ahagaragara “Ubwumvikane bw’impuguke 2026 bujyanye no kuvura indwara ya kanseri ya Hepatocellular Carcinoma,” ubu protocole yo kuvura irangwa cyane. Filozofiya yibanze yavuye muburyo bumwe-bujyanye nuburyo bwose bushingiye ku ngamba zishingiye ku byago.

Amateka, ibipimo byo kwisubiramo nyuma yo kubagwa byagaragaye hagati ya 50% na 70%. Nyamara, amakuru mashya yerekana ko guhuza ubuvuzi bwa sisitemu hamwe n’ibikorwa byaho bishobora kugabanya cyane iyi mibare. Amabwiriza ya 2026 yerekana ubwoko bubiri butandukanye bwo kwisubiramo: kugaruka hakiri kare (mumyaka ibiri) no gutinda kugaruka (nyuma yimyaka ibiri). Buri kimwe gisaba uburyo butandukanye bwo kuvura.

Gusubiramo kare ikunze guhuzwa na micro-metastase ihari mbere yo kubagwa cyangwa gukwirakwizwa. Ibinyuranye, gutinda ubusanzwe bituruka ku bibyimba bya de novo bivuka bitewe n'indwara y'umwijima idakira, nka hepatite B cyangwa cirrhose. Kumenya iri tandukaniro ningirakamaro muguhitamo neza imiti ivura.

Ibintu by'ingenzi bishobora guteza impanuka

Ubu abaganga bakoresha ibipimo byihariye kugirango bamenye abarwayi bakeneye ubuvuzi bukabije nyuma yo kubagwa. Ibi bintu bishobora guteza ibyago byinshi birimo:

• Ibibyimba byinshi: Kubaho kw'ibibyimba byinshi.
• Ingano ya Tumor: Diameter ntarengwa irenze cm 5.
• Icyiciro cyo Gutandukanya: Icyiciro cya Edmondson III-IV, byerekana selile zitandukanye.
• Igitero cy'amaraso: Microvascular (MVI) cyangwa gutera macrovasculaire.
• Lymph Node Metastasis: Gukwirakwira kuri lymph node.
• Tumor Rupture: Amateka yo guturika bidatinze mbere yo kwangwa.
• Urwego rwa Biomarker: Guhora udasanzwe Alpha-fetoprotein (AFP) cyangwa Des-gamma-carboxy prothrombin (DCP) nyuma yo kubagwa.

Abarwayi bagaragaza ibyo biranga bafatwa nkabakandida bambere bavura cyane, harimo immunotherapie hamwe naba agent bagenewe.

Ibintu bigira ingaruka zitinze

Kubisubiramo bitinze, intumbero ihinduka mugucunga indwara yumwijima. Abaterankunga b'ingenzi barimo:

• Imyaka: Abarwayi barengeje imyaka 60.
• Igikorwa cya virusi: Indwara ya virusi idakira (HBsAg positif).
• Indwara ya Cirrhose: Amanota menshi ya Ishak cyangwa Scheuer yerekana fibrosis yateye imbere.
• Hypoalbuminemia: Urwego rwa serumu nkeya ya alubumu yerekana imikorere mibi yumwijima.

Ubuyobozi bwiri tsinda bushyira imbere imiti igabanya ubukana bwigihe kirekire no gukurikirana buri gihe kugirango hirindwe ibibyimba bishya.

Igihe cyibihe na Immunotherapy Kwishyira hamwe

Imwe mumavugurura yingenzi mumabwiriza ya 2026 nuguhuza kumugaragaro uburyo bwo kuvura antitumor sisitemu muburyo bwimikorere. Ikimenyetso cyinjira kanseri y'umwijima kwivuza mu "gihe-cyo gukingira indwara." Mbere, ibiyobyabwenge bya sisitemu byari bigenewe imanza zateye imbere, zidashobora gukemurwa. Noneho, zirakoreshwa muburyo bwo gukuraho indwara ya microscopique isigaye.

Kuzamuka kwa hamwe

Igeragezwa rya kliniki iheruka kwerekana ko guhuza imiti igabanya ubukana (ICIs) hamwe na tirozine kinase inhibitor (TKIs) cyangwa antibodiyite zirwanya VEGF bitanga umusaruro ushimishije ugereranije na monotherapy. Gahunda ya "T + A" (Atezolizumab wongeyeho Bevacizumab) hamwe n’imbere mu gihugu nka Donafenib wongeyeho Toripalimab byagaragaje ibisubizo bitanga icyizere cyo kwagura Ubuzima busubira inyuma (RFS).

Ku barwayi bafite ibyago byinshi, immunotherapy ya agent imwe hamwe nibiyobyabwenge nka Sintilimab cyangwa Nivolumab nabyo byagaragaye ko bifite akamaro. Izi miti zifasha kongera gukora sisitemu yumubiri kugirango tumenye kandi dusenye selile zisigaye. Ubwumvikane bwa 2026 bwerekana neza ko ubwo buvuzi butakigeragezwa ariko burasabwa amahitamo asanzwe yujuje ibyiciro by’amatsinda menshi.

Ibimenyetso Bishyigikira Gahunda Nshya

Imibare yatanzwe mu nama z’amasomo aherutse kubera muri Shanghai yerekana ko ibiyobyabwenge bimwe na bimwe byibasiye imiti bishobora kugera ku mwaka umwe wa RFS igera kuri 87% mu baturage bafite ibyago byinshi. Byongeye kandi, uburyo bwo guhuza abarwayi bafite ibibyimba binini (> cm 5) na MVI bavuze ko umwaka umwe muri rusange ubuzima bwo hejuru burenga 96%. Iyi mibare yerekana ihinduka rikomeye kuva ku bipimo byamateka.

Ariko, gukoresha imiti ikomeye bisaba guhitamo neza abarwayi. Ntabwo umurwayi wese yunguka kimwe, kandi ubushobozi bwibintu biterwa n’ubudahangarwa (irAEs) bisaba uburyo bukomeye bwo gucunga umutekano.

Ubuvuzi bwaho: Guhuriza hamwe no Kunonosora

Mugihe ubuvuzi bwa sisitemu bugenda bugaragara, ubuvuzi bwaho bukomeza kuba ingenzi muri algorithm yo kuvura 2026. Ubwumvikane buvuguruwe butanga umurongo ngenderwaho wigihe nuburyo bwo gukoresha Transarterial Chemoembolisation (TACE), Hepatic Arterial Infusion Chemotherapy (HAIC), na radiotherapi.

Amasezerano ya TACE ya Adjuvant

Ku barwayi bafite ibyago byinshi, TACE yingirakamaro irasabwa hafi ukwezi nyuma yo kubagwa. Porotokole isanzwe ikubiyemo amasomo imwe kugeza kuri abiri. Iki gihe cyemerera umwijima gukira kubagwa mugihe ugamije metastase isigaye iterwa namaraso. TACE ikora muguhagarika amaraso mumasemburo asigaye kandi ikanatanga umwijima mwinshi wa chimiotherapie umwijima.

HAIC yo gutera Microvascular

Ikintu cyingenzi cyaranze ivugurura rya 2026 nicyifuzo cyihariye cya HAIC kubarwayi bafite Microvasculaire (MVI). Ukoresheje gahunda ya FOLFOX, HAIC yerekanwe kunoza cyane RFS muri iri tsinda. Bitandukanye na TACE, ikubiyemo imiyoboro y'amaraso, HAIC ikomeza gutera imiti ya chimiotherapie, ikomeza ibiyobyabwenge byinshi mumyanya yibibyimba hamwe n'ingaruka nke za sisitemu.

Radiotherapy ya Narrow Margins

Amagambo yo kubaga ni ibintu bikomeye byerekana ko bizagaruka. Ku barwayi bafite inzitizi zifatika (cm1 cm), MVI nziza, cyangwa portal vein tumor trombus, Intensity-Modulated Radiation Therapy (IMRT) ubu ni igikoresho cyingenzi. Radiotherapy ihindura neza uburiri bwibibyimba, bikagabanya ibyago byo kongera kubaho. Nibyingenzi byumwihariko mugihe ubundi kubagwa bidashoboka.

Imicungire yuzuye na Fondasiyo ya virusi

Ubwumvikane bwa 2026 bushimangira ko kuvura ikibyimba ari kimwe cya kabiri cyintambara; gucunga indwara yumwijima yibanze ningirakamaro. Ubu buryo "bwo kuyobora amasomo yose" butuma umwijima udatera kanseri nshya.

Ubuvuzi buteganijwe bwa virusi

Urebye ko umubare munini wa kanseri y'umwijima indwara zo mu Bushinwa zifitanye isano na Hepatitis B Virusi (HBV), imiti igabanya ubukana bwa virusi ntishobora kubaho. Amabwiriza ategeka gukoresha nucleos zikomeye (t) ingero zingirakamaro hamwe nimbogamizi zikomeye zo guhangana, nka Entecavir cyangwa Tenofovir. Kurwanya kwigana virusi ntabwo birinda imikorere yumwijima gusa ahubwo binagabanya byimazeyo ibyago byo kongera kanseri.

Ku barwayi ba Hepatite C (HCV), birasabwa ko virusi zidakira (DAAs), nubwo hakenewe ibimenyetso byinshi kugira ngo hemezwe ingaruka zabyo mu gukumira indwara nyuma yo kubagwa ugereranije no kuvura HBV.

Uruhare rwubuvuzi gakondo bwabashinwa

Ubuvuzi bwuzuye bukomeje kugira uruhare mubijyanye no kuvura Ubushinwa. Ubwumvikane busaba Huaier Granule kubarwayi nyuma yo kwangwa bikabije. Ubuvuzi bwa Clinical bwerekana ko bushobora gufasha kubuza kubaho no kuramba muri rusange, bukaba ari ubuvuzi bufasha hamwe nubuvuzi busanzwe.

Gutezimbere Gutezimbere no Gufata Ibyemezo

Usibye ubuvuzi bwihariye, uburyo bwo gufata icyemezo kuri gahunda yo kuvura nabwo bwaravuguruwe. Imiterere ya 2026 ya sisitemu yo kubika kanseri y’umwijima ya Barcelona (BCLC), yemewe cyane mu Bushinwa, ubu ikubiyemo uburyo bushya bwo gufata ibyemezo bizwi ku izina rya CUSE.

Urwego rwo gufata ibyemezo

CUSE isobanura Ingorabahizi, Kudashidikanya, Subjectivite, n'amarangamutima. Uru rwego ruyobora amatsinda atandukanye gusuzuma ibipimo bine bikomeye:

• Ingorabahizi: Kwemera imiterere yindwara nuburyo bwo kuvura buhari.
• Kutamenya neza: Gukemura ikibazo kidasobanutse hamwe nuburyo bugenda bwerekana ibimenyetso byubuvuzi.
• Subjectivite: Kubaha ibyifuzo byabaganga nabarwayi.
• Amarangamutima: Urebye ibyakubayeho, ibyateganijwe, n'imyizerere yawe.

Muguhuza ibi bintu byabantu nibimenyetso byubuvuzi, urwego rwa CUSE rwemeza ko ibyemezo byokuvura bishingiye kubarwayi, bikarenga algorithms zikomeye kuri gahunda yo kwita kubantu.

Amakuru agezweho muri BCLC Ibyifuzo

Ivugurura rya 2026 BCLC ryerekana impinduka zitandukanye:

• Icyiciro 0 / A: Ubuvuzi bwa stereotactique yumubiri (SBRT) hamwe na Radioarteri ya Transarterial (TARE) ubu bizwi nkuburyo bwo kuvura hamwe no kubaga no gukuraho.
• Icyiciro B: Amabwiriza yibutsa ko ibimenyetso biriho bidahagije kugira ngo dusabe buri gihe guhuza imiti ivura no kuvura buri gihe abarwayi bo hagati.
• Icyiciro C: Immunotherapy ifatanije nubuvuzi bugamije gushyirwaho neza nkumurongo wambere wubuvuzi.

Kugereranya Isesengura ryuburyo bwo kuvura

Kugira ngo ufashe abarwayi n'imiryango gusobanukirwa n'amahitamo, imbonerahamwe ikurikira iragereranya imiti y'ibanze ivura isabwa muri 2026.

Intambwe ku yindi Ubuyobozi bwo Kwivuza nyuma yo kubagwa muri 2026

Kuyobora urugendo nyuma yibikorwa birashobora kuba byinshi. Ukurikije ibyumvikanyweho vuba aha, dore inzira yoroheje kubarwayi barimo kanseri y'umwijima kwivuza mu Bushinwa.

• Intambwe ya 1: Isuzuma ry'ingaruka. Ako kanya nyuma yo kubagwa, raporo ya patologiya isesengurwa kubintu bishobora guteza ibyago byinshi nka MVI, ingano y'ibibyimba, hamwe n'icyiciro cyo gutandukanya. Ibi bigena inzira yo kuvura ikurikira.
• Intambwe ya 2: Gutangiza Ubuvuzi Bwibanze. Abarwayi bose, batitaye ku byago, batangira cyangwa bakomeza kuvura virusi niba HBV / HCV ari nziza. Inkunga yumwijima irashimangirwa.
• Intambwe ya 3: Guhitamo Ingamba zo Guhuza.
  • Abarwayi bafite ibyago bike: Gukurikiranwa buri mezi 3-6.
  • Abarwayi bafite ibyago byinshi: Ikiganiro cyubuvuzi bwa sisitemu (ICI / TKI) na / cyangwa ubuvuzi bwaho (TACE / HAIC / Radiotherapy).
• Intambwe ya 4: Gushyira mubikorwa Ubuvuzi Bumwe. Niba byerekanwe, ibiyobyabwenge bya sisitemu biratangira, akenshi bifatanije nibikorwa byaho nka TACE ukwezi kumwe nyuma ya op.
• Intambwe ya 5: Gukurikirana umutekano. Kugenzura buri gihe uburozi bwibiyobyabwenge, harimo imisemburo yumwijima, imikorere ya tiroyide, nibimenyetso bya pneumonite cyangwa colitis.
• Intambwe ya 6: Gukurikirana igihe kirekire. Abarwayi bafite ibyago byinshi bipimisha amashusho na biomarker buri mezi 3. Gukurikirana neza nka ctDNA birashobora gukoreshwa aho bihari.

Gutekereza ku Biciro no Kwishingira Ubwishingizi

Kugera ku buvuzi bugezweho ni ikibazo gihangayikishije abarwayi. Muri 2026, imiterere yimari ya kanseri y'umwijima ubuvuzi mu Bushinwa bwateye imbere cyane kubera ivugurura ry’ubwishingizi bw’igihugu.

Kuvugurura ubwishingizi

Iterambere rikomeye ni ugushyiramo indangantego nyinshi za PD-1 mu gihugu mu rutonde rw’ibiyobyabwenge by’igihugu (NRDL). Ibiyobyabwenge nka Finolimab nabandi babonye ibimenyetso byabo byagutse kugirango barinde kanseri yumwijima, bigatuma bihendutse kubarwayi basanzwe. Uku kwimuka kwagabanije cyane amafaranga yo mu mufuka yo gukingira indwara, mbere yari ahenze cyane.

Byongeye kandi, ubuvuzi bugamije hamwe nuburyo bumwe bwo gutabara bwibanze bikubiye muri gahunda yubwishingizi bwubuvuzi. Umubare nyawo wo kwishyurwa uratandukanye bitewe n'akarere n'ubwoko bw'ubwishingizi bwihariye, ariko icyerekezo ni uburyo bwagutse bwo kuvura uburyo bushya bwo kuvura bwagaragaye ko buramba.

Ikigereranyo cyibiciro

Mugihe ibiciro byihariye bitandukanye nibitaro nakarere, abarwayi bagomba guteganya amafaranga ajyanye na:

• Ibiciro by'ibiyobyabwenge: Yamanutse ku buryo bugaragara ku biyobyabwenge bifite ubwishingizi; ibiyobyabwenge bitumizwa mu mahanga bikomeza kuba hejuru.
• Ibiciro byuburyo bukurikira: TACE, HAIC, na radiotherapi bikubiyemo ibitaro n'amafaranga ya tekiniki, ahanini yishyurwa n'ubwishingizi.
• Igiciro cyo gukurikirana: Gusuzuma buri gihe CT / MRI hamwe no gupima amaraso bigize amafaranga asubiramo.

Abarwayi barasabwa kugisha inama abashinzwe imibereho myiza y’ibitaro cyangwa abahuzabikorwa b’ubwishingizi kugirango barusheho kubona inyungu. Ibitaro byinshi byo mu rwego rwo hejuru mu mijyi nka Shanghai na Beijing bifite amashami yihariye yo gufasha mu kwishingira ubwishingizi na gahunda z’ubufasha.

Kubona Ibitaro Byukuri ninzobere

Guhitamo ikigo cyubuvuzi gikwiye ningirakamaro kubisubizo byiza. Ubushinwa bufite ibigo byinshi byo ku isi bizobereye kuri onkologiya ya hepatobiliary. “Ubushinwa bushya bwo guhanga udushya kuri kanseri ya Hepato-Biliary,” bwatangijwe vuba aha, buhuza ibigo nderabuzima birenga 20 kugira ngo ubuvuzi busanzwe kandi buteze imbere ubushakashatsi.

Ibigo Bikuru byo kuvura Kanseri Yumwijima

Ibitaro byinshi bizwiho ubuhanga mu gushyira mu bikorwa umurongo ngenderwaho wa 2026:

• Ibitaro bya Zhongshan (Kaminuza ya Fudan, Shanghai): Iki kigo kiyobowe nabashakashatsi nka Fan Jia na Zhou Jian, iki kigo nintangarugero muguhindura umwijima, kubaga no kubaga, hamwe nubushakashatsi buvura. Yagize uruhare runini mu gutegura ubwumvikane bwa 2026.
• Beijing Tsinghua Changgung Ibitaro: Azwiho uburyo bushya bwo guhanga udushya, harimo Yttrium-90 radioembolisation hamwe nitsinda ryinshi (MDT).
• Ibitaro bya Kanseri Ishuri Rikuru ry'Ubuvuzi mu Bushinwa (Beijing): Umuyobozi mubigeragezo byo kuvura no kuvura oncology yuzuye.
• Ibitaro by’Ubushinwa (Kaminuza ya Sichuan): Itanga ubuvuzi budasanzwe ku barwayi bo mu burengerazuba bw'Ubushinwa bafite ubushobozi bwo kubaga no gutabara.

Ibyo gushakisha mubitaro

Mugihe bashaka kwivuza, abarwayi bagomba gusuzuma niba ibitaro bitanga:

• Itsinda Ryinshi (MDT) Inama: Iremeza ibitekerezo byabaganga babaga, oncologiste, radiologiste, naba patologiste.
• Kugera kubigeragezo byamavuriro: Amahirwe yo kwakira ibisekuruza bizaza mbere yo kuboneka.
• Ibikoresho bigezweho byo gusuzuma: Kuboneka kugenzura ctDNA no kwerekana amashusho menshi.
• Uburyo bwiza bwo Kwitaho: Inkunga yo kuvura virusi, imirire, hamwe ninama zo mumitekerereze.

Ibyiza n'ibibi byo kuvura bigezweho

Nubwo iterambere muri 2026 ritanga icyizere, ni ngombwa gusuzuma inyungu zirwanya ibibi bishobora kubaho.

• Ibyiza:
  • Kurokoka neza: Kwiyongera gukomeye mubuzima busubiramo (RFS) hamwe no Kurokoka Muri rusange (OS) kumatsinda afite ibyago byinshi.
  • Kwishyira ukizana: Ubuvuzi bwateguwe bushingiye kumiterere yihariye ya patologiya hamwe na profil genetique.
  • Kugabanuka Kwisubiramo: Kurandura burundu micrometastase bigabanya amahirwe yo kugaruka kwa kanseri hakiri kare.
  • Inkunga y'Ubwishingizi: Birashoboka cyane kubera politiki yo kwishyura igihugu.
• Ibibi:
  • Ingaruka zo ku ruhande: Immunotherapy irashobora gutera indwara ziterwa nubudahangarwa zifata umwijima, ibihaha, cyangwa umutima. Ibiyobyabwenge bigamije bishobora gutera hypertension cyangwa syndrome yintoki.
  • Ingorabahizi: Gucunga imiti ivura bisaba amatsinda yubuvuzi afite uburambe no gukurikirana kenshi.
  • Ibisubizo Bitandukanye: Ntabwo abarwayi bose bitabira immunotherapy; biomarkers guhanura igisubizo biracyahinduka.
  • Umutwaro w'amafaranga: Nubwo ubwishingizi, bimwe bishya hamwe cyangwa amafaranga yo kwita kubufasha arashobora kuba ingirakamaro.

Icyerekezo kizaza hamwe nubushakashatsi

Umwanya wa kanseri y'umwijima kuvura ni imbaraga. Urebye hejuru ya 2026, uduce twinshi twiteguye gutera imbere. Ishyirwaho ryububiko bwigihugu nubufatanye nkubushinwa bushya bwo guhanga udushya kuri kanseri ya Hepato-Biliary bizihutisha kuvumbura amakuru.

Ubuzima bwa Digital hamwe na AI Kwishyira hamwe

Ubwenge bwa artificiel burimo gukoreshwa muguhishurira ingaruka zishobora kubaho no kunoza gahunda yo kuvura. Imiyoboro ya sisitemu yorohereza gukurikirana kure, ituma abarwayi batangaza ibimenyetso mugihe nyacyo, bifasha mukumenya hakiri kare ibintu bibi. Insanganyamatsiko ya "numero yubushobozi bwimbaraga" yagaragaye mumanama yumwaka wamasomo yerekana iyi mpinduka yerekeza kubuhanga buhanga.

Intego zo kuvura udushya

Ubushakashatsi burakomeje mubitego bishya birenze PD-1 / VEGF. Antibodies zidasanzwe, CAR-T ivura ingirabuzimafatizo zagenewe ibibyimba bikomeye, hamwe ninkingo zo kuvura ziri mubyiciro bitandukanye byiterambere ryamavuriro. Intego ni uguhindura ibibyimba "bikonje" mo "bishyushye" byakira cyane immunotherapy.

Ubufatanye ku Isi

Abashakashatsi b'Abashinwa bakorana umwete na bagenzi babo mpuzamahanga. Ubushakashatsi butandukanye bwibanze ku bigo byo mu bihugu byinshi buragenda buba rusange, byemeza ko ibipimo by’ubuvuzi mu Bushinwa bihuza n’imikorere myiza ku isi mu gihe bikemura ibibazo byihariye by’ibyorezo by’indwara, urugero nka HBV.

Umwanzuro

Umwaka wa 2026 uranga ibihe bihinduka muri kanseri y'umwijima kwivuza mu Bushinwa. Hamwe no kurekura impuguke zavuguruwe hamwe no guhuza sisitemu yo gutera imbere, abarwayi ubu bafite uburyo bunoze, bunoze, kandi bwihariye bwo kwita kubantu. Impinduka zijyanye no guhuza sisitemu yubudahangarwa hamwe n’ibikorwa byaho bitanga ibyiringiro bishya byo kugabanya igipimo kinini cyo kwisubiramo nyuma yo kubagwa.

Icy'ingenzi muri iri terambere ni ugushimangira ibyiciro by’ingaruka, kwemeza ko abarwayi bafite ibyago byinshi bahabwa imiti igabanya ubukana mu gihe abarwayi bafite ibyago bike birinda uburozi budakenewe. Hamwe n’imicungire ikomeye ya virusi no kunoza ubwishingizi, icyerekezo cy’abarwayi ba kanseri y’umwijima ni cyiza kuruta mbere hose. Mugukoresha ubuhanga bwibigo byubuvuzi byo mu rwego rwo hejuru no gukurikiza amabwiriza agezweho, abarwayi barashobora kuyobora urugendo rwabo rwo kwivuza bafite ikizere kandi bafite icyizere.

Mugihe ubushakashatsi bukomeje kugenda bwiyongera kandi n’ikoranabuhanga rishya rigaragara, ubufatanye hagati y’abaganga, abashakashatsi, n’abarwayi buzakomeza kuba imbarutso yo kurushaho gutera imbere mu mibereho no mu mibereho. Kubantu bose bahuye nacyo kanseri y'umwijima, gukomeza kumenyeshwa ibyagezweho no gushaka ubuvuzi mubigo byihariye nintambwe yingenzi cyane kugirango igerweho neza.